UBS Group
CVM icon

UBS Group’s CEL-SCI Corp CVM Stock Holding History

UBS Group’s Portfolio CVM Stock Details CVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-52,880
Closed -$13.8M – 9618
2021
Q2 		$13.8M Buy
52,880
+25,860
+96% +$16M ﹤0.01% 1780
2021
Q1 		$12.3M Buy
27,020
+26,357
+3,975% +$14.4M ﹤0.01% 1778
2020
Q4 		$232K Buy
+663
New +$262K ﹤0.01% 5153
2020
Q3 		– Sell
-1,667
Closed -$746K – 8047
2020
Q2 		$746K Buy
+1,667
New +$684K ﹤0.01% 3776

Other funds holding CVM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group's CVM Position: Q1 2026 in Review

UBS Group increased its CEL-SCI Corp (CVM) stake by 26% in Q1 2026, buying an estimated $16K and bringing the position to 16,637 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7332.

UBS Group first reported a position in CVM in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.55M in Q3 2021. 39 funds tracked by Wall St. Rank hold CVM as of Q1 2026.

  • UBS Group held 16,637 shares of CEL-SCI Corp worth $53.4K as of Q1 2026.
  • UBS Group bought 3,444 CEL-SCI Corp shares in Q1 2026, an estimated $16K.
  • CEL-SCI Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7332 holding.
  • UBS Group first reported a position in CEL-SCI Corp in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's CEL-SCI Corp position peaked at $2.55M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.